argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026GlobeNewsWire • 08/03/26
A portfolio manager says investors are looking overseas as Magnificent Seven worries grow. Here are the stocks and sectors he favorsCNBC • 07/31/26
Forte Biosciences shares surge after argenx agrees to acquire company for $2.2BProactive Investors • 07/27/26
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology PipelineBusiness Wire • 07/27/26
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology PipelineGlobeNewsWire • 07/27/26
argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026GlobeNewsWire • 07/16/26
Chai Discovery Enters Into Collaboration Agreement With argenx to Advance AI-Driven Immunology BreakthroughsBusiness Wire • 07/15/26
This Profitable Autoimmune Biotech Trades Near A High And A Buy PointInvestors Business Daily • 07/06/26